Wolfgang Dummer

4.8k total citations · 1 hit paper
56 papers, 3.9k citations indexed

About

Wolfgang Dummer is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Wolfgang Dummer has authored 56 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 12 papers in Oncology and 9 papers in Genetics. Recurrent topics in Wolfgang Dummer's work include T-cell and B-cell Immunology (23 papers), Immunotherapy and Immune Responses (18 papers) and Immune Cell Function and Interaction (12 papers). Wolfgang Dummer is often cited by papers focused on T-cell and B-cell Immunology (23 papers), Immunotherapy and Immune Responses (18 papers) and Immune Cell Function and Interaction (12 papers). Wolfgang Dummer collaborates with scholars based in United States, Germany and Canada. Wolfgang Dummer's co-authors include Argyrios N. Theofilopoulos, Roberto Baccalà, Brian R. Lawson, Dwight H. Kono, Patricia A. Walicke, Tiffani K. Hamilton, Norbert Wagner, Ralph A. Reisfeld, Andreas G. Niethammer and Charles D. Surh and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Wolfgang Dummer

55 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)

2005 373 citations Michelle A. Lowes, Francesca Chamian et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wolfgang Dummer United States	29	2.7k	891	581	499	451	56	3.9k
Toyoko Kikuchi United States	25	3.1k 1.1×	625 0.7×	1.7k 3.0×	379 0.8×	587 1.3×	34	4.2k
Philip E. Stuart United States	28	2.2k 0.8×	554 0.6×	989 1.7×	413 0.8×	731 1.6×	45	3.1k
Timothy R. D. J. Radstake Netherlands	34	2.5k 0.9×	594 0.7×	274 0.5×	1.3k 2.6×	960 2.1×	81	4.5k
Nobuo Kanazawa Japan	27	1.6k 0.6×	559 0.6×	322 0.6×	344 0.7×	1.1k 2.5×	131	3.5k
Junliang Pan United States	27	2.8k 1.0×	1.3k 1.4×	284 0.5×	150 0.3×	839 1.9×	38	4.6k
Percy Lehmann Germany	31	2.1k 0.8×	1.1k 1.3×	1.4k 2.4×	1.0k 2.1×	535 1.2×	92	4.5k
Barbara White United States	23	1.2k 0.4×	452 0.5×	278 0.5×	734 1.5×	454 1.0×	50	2.5k
Michael S. Vincent United States	30	1.3k 0.5×	432 0.5×	487 0.8×	661 1.3×	356 0.8×	75	2.9k
Manel Juan Spain	36	1.7k 0.6×	912 1.0×	154 0.3×	195 0.4×	827 1.8×	180	4.1k
Ming-Hong Xie United States	14	2.1k 0.8×	657 0.7×	338 0.6×	199 0.4×	709 1.6×	31	3.3k

Countries citing papers authored by Wolfgang Dummer

Since Specialization

Citations

This map shows the geographic impact of Wolfgang Dummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Dummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Dummer more than expected).

Fields of papers citing papers by Wolfgang Dummer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Dummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Dummer. The network helps show where Wolfgang Dummer may publish in the future.

Co-authorship network of co-authors of Wolfgang Dummer

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Dummer. A scholar is included among the top collaborators of Wolfgang Dummer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Dummer. Wolfgang Dummer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garcia‐Manero, Guillermo, Lucy Yan, & Wolfgang Dummer. (2023). Phase 1b clinical study of IRAK 1/4 inhibition for low-risk myelodysplastic syndromes refractory/resistant to prior therapies.. Journal of Clinical Oncology. 41(16_suppl). TPS7085–TPS7085. 1 indexed citations

Malik, Anuj, et al.. (2023). 88. Fostamatinib for the Treatment of Hospitalized Patients With COVID-19 Who Required Oxygen Supplementation: Results of a Phase 3 Trial. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Krueger, James G., Hans D. Ochs, Piyush M. Patel, et al.. (2008). Effect of Therapeutic Integrin (CD11a) Blockade with Efalizumab on Immune Responses to Model Antigens in Humans: Results of a Randomized, Single Blind Study. Journal of Investigative Dermatology. 128(11). 2615–2624. 17 indexed citations

Guttman‐Yassky, Emma, Yulia Vugmeyster, Michelle A. Lowes, et al.. (2008). Blockade of CD11a by Efalizumab in Psoriasis Patients Induces a Unique State of T-Cell Hyporesponsiveness. Journal of Investigative Dermatology. 128(5). 1182–1191. 48 indexed citations

Genovese, Mark C., Jeffrey Kaine, Mitchell B. Lowenstein, et al.. (2008). Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo‐controlled, dose‐ranging study. Arthritis & Rheumatism. 58(9). 2652–2661. 157 indexed citations

Baccalà, Roberto, Deborah A. Witherden, Rosana González‐Quintial, et al.. (2005). γδ T Cell Homeostasis Is Controlled by IL-7 and IL-15 Together with Subset-Specific Factors. The Journal of Immunology. 174(8). 4606–4612. 70 indexed citations

Kieper, William C., Amy E. Troy, Chris Ramsey, et al.. (2005). Cutting Edge: Recent Immune Status Determines the Source of Antigens That Drive Homeostatic T Cell Expansion. The Journal of Immunology. 174(6). 3158–3163. 214 indexed citations

Vugmeyster, Yulia, Joseph C. Beyer, Kathy Howell, et al.. (2005). Depletion of B Cells by a Humanized Anti-CD20 Antibody PRO70769 in Macaca Fascicularis. Journal of Immunotherapy. 28(3). 212–219. 60 indexed citations

Jullien, D., JC Prinz, Richard G. Langley, et al.. (2004). T-Cell Modulation for the Treatment of Chronic Plaque Psoriasis with Efalizumab (Raptiva™): Mechanisms of Action. Dermatology. 208(4). 297–306. 91 indexed citations

10.

Kaempgen, Eckhart, et al.. (2003). Late‐type allergy to Ultravist® (iopromid). Allergy. 58(3). 261–262. 1 indexed citations

11.

Gottlieb, Alice B., Bruce Miller, Nicholas J. Lowe, et al.. (2003). Subcutaneously Administered Efalizumab (Anti-CD 11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis. Journal of Cutaneous Medicine and Surgery. 7(3). 198–207. 4 indexed citations

12.

Lebwohl, Mark, Stephen K. Tyring, Tiffani K. Hamilton, et al.. (2003). A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis. New England Journal of Medicine. 349(21). 2004–2013. 424 indexed citations

13.

Santiago‐Raber, Marie‐Laure, Brian R. Lawson, Wolfgang Dummer, et al.. (2001). Role of Cyclin Kinase Inhibitor p21 in Systemic Autoimmunity. The Journal of Immunology. 167(7). 4067–4074. 73 indexed citations

14.

Dummer, Wolfgang, Bettina Ernst, Eric M. Leroy, Dong‐Sup Lee, & Charles D. Surh. (2001). Autologous Regulation of Naive T Cell Homeostasis Within the T Cell Compartment. The Journal of Immunology. 166(4). 2460–2468. 139 indexed citations

15.

Surh, Charles D., Bettina Ernst, Dong‐Sup Lee, Wolfgang Dummer, & Eric M. Leroy. (2000). Role of Self-Major Histocompatibility Complex/Peptide Ligands in Selection and Maintenance of a Diverse T Cell Repertoire. Immunologic Research. 21(2-3). 331–340. 8 indexed citations

16.

Ogilvie, Patricia, Axel Trautmann, Wolfgang Dummer, et al.. (2000). Pemphigoid gestationis ohne Blasenbildung. Der Hautarzt. 51(1). 25–30. 9 indexed citations

17.

Keilholz, Ulrich, Martina Willhauck, Donata Rimoldi, et al.. (1998). Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC melanoma cooperative group. European Journal of Cancer. 34(5). 750–753. 101 indexed citations

18.

Dummer, Wolfgang, Christian Rosé, & E.‐B. Bröcker. (1998). Expression of CD30 on T helper cells in the inflammatory infiltrate of acute atopic dermatitis but not of allergic contact dermatitis. Archives of Dermatological Research. 290(11). 598–602. 23 indexed citations

19.

Dummer, Wolfgang, et al.. (1996). Interleukin‐10 production in malignant melanoma: Preferential detection of IL‐10‐secreting tumor cells in metastatic lesions. International Journal of Cancer. 66(5). 607–610. 7 indexed citations

20.

Dummer, Wolfgang, et al.. (1996). Interleukin-10 production in malignant melanoma: Preferential detection of IL-10-secreting tumor cells in metastatic lesions. International Journal of Cancer. 66(5). 607–610. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact